XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Schedule of Reconciliation of Numerator and Denominator of Basic and Diluted Earnings per Share

A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands):

						Three Months Ended March 31,
						2024						2023
Numerator:
Net loss attributable to Surgery Partners, Inc.						$	(12.4)					$	(24.9)
Denominator:
Weighted average common shares outstanding:
Basic						125,972						125,206
Diluted (1)						125,972						125,206
Net loss per share attributable to common stockholders:
Basic						$	(0.10)					$	(0.20)
Diluted (1)						$	(0.10)					$	(0.20)
Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive:
Stock options						1,237						1,338
Restricted shares						148						67

(1)The impact of potentially dilutive securities for all periods were not considered because the effect would be anti-dilutive.

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration